Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Malignant gliomas are highly lethal neoplasms with limited treatment options. We previously found that the heparan sulfate proteoglycan
glypican 1
(
GPC1
) is universally and highly expressed in human gliomas. In this study, we investigated the biological activity of
GPC1
expression in both human
glioma
cells and normal astrocytes in vitro. Expression of
GPC1
inactivates the G1/S checkpoint and strongly stimulates DNA replication. Constitutive expression of
GPC1
causes DNA rereplication and DNA damage, suggesting a mutagenic activity for
GPC1
.
GPC1
expression leads to a significant downregulation of the tumor suppressors pRb, Cip/Kip cyclin-dependent kinase inhibitors (CKIs), and CDH1, and upregulation of the pro-oncogenic proteins cyclin E, cyclin-dependent kinase 2 (CDK2), Skp2, and Cdt1. These
GPC1
-induced changes are accompanied by a significant reduction in all types of D cyclins, which is independent of serum supplementation. It is likely that
GPC1
stimulates the so-called Skp2 autoinduction loop, independent of cyclin D-CDK4/6. Knockdown of Skp2, CDK2, or cyclin E, three key elements within the network modulated by
GPC1
, results in a reduction of the S phase and aneuploid fractions, implying a functional role for these regulators in
GPC1
-induced S phase entry and DNA rereplication. In addition, a significant activation of both the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathways by
GPC1
is seen in normal human astrocytes even in the presence of growth factor supplement. Both pathways are constitutively activated in human gliomas. The surprising magnitude and the mitogenic and mutagenic nature of the effect exerted by
GPC1
on the cell cycle imply that
GPC1
may play an important role in both
glioma
tumorigenesis and growth.
...
PMID:Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes. 2741 36